"Neuroimmunomodulation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM.
| Descriptor ID |
D015213
|
| MeSH Number(s) |
G07.265.758 G11.561.630 G12.535.575
|
| Concept/Terms |
Neuroimmunomodulation- Neuroimmunomodulation
- Neuroimmune Processes
- Neuroimmune Mechanisms
- Mechanism, Neuroimmune
- Mechanisms, Neuroimmune
- Neuroimmune Mechanism
- Neuroimmune Process
- Process, Neuroimmune
|
Below are MeSH descriptors whose meaning is more general than "Neuroimmunomodulation".
Below are MeSH descriptors whose meaning is more specific than "Neuroimmunomodulation".
This graph shows the total number of publications written about "Neuroimmunomodulation" by people in this website by year, and whether "Neuroimmunomodulation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuroimmunomodulation" by people in Profiles.
-
Chakravarty D, Das Sarma J. Murine-?-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2. J Neurovirol. 2021 04; 27(2):197-216.
-
Jensen BK, Roth LM, Grinspan JB, Jordan-Sciutto KL. White matter loss and oligodendrocyte dysfunction in HIV: A consequence of the infection, the antiretroviral therapy or both? Brain Res. 2019 12 01; 1724:146397.
-
Solomos AC, Rall GF. Get It through Your Thick Head: Emerging Principles in Neuroimmunology and Neurovirology Redefine Central Nervous System "Immune Privilege". ACS Chem Neurosci. 2016 Apr 20; 7(4):435-41.
-
Vitaliti G, Pavone P, Mahmood F, Nunnari G, Falsaperla R. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches. Hum Vaccin Immunother. 2014; 10(4):868-75.
-
Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, Neuwelt EA. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab. 2013 Jan; 33(1):13-21.
-
O'Donnell LA, Rall GF. Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin. J Neuroimmune Pharmacol. 2010 Sep; 5(3):443-55.
-
Hohlfeld R, Dalakas MC. Basic principles of immunotherapy for neurologic diseases. Semin Neurol. 2003 Jun; 23(2):121-32.
-
Stryjewski G, Dalton HJ. Circulating leptin: mediator or marker of the neuroendocrinological stress response? Crit Care Med. 2001 Dec; 29(12):2397-8.
-
Dalakas MC. Neuroimmunotherapy: a practical approach to the treatment of immune-mediated neurologic diseases. Semin Neurol. 1994 Jun; 14(2):97-105.